Use of CSF biomarkers in Alzheimer’s disease clinical trials

被引：0
|
作者：
K. Blennow
H. Zetterberg
机构：
[1] the Sahlgrenska Academy at Göteborg University,Clinical Neurochemistry Laboratory
[2] The Sahlgrenska Academy at Göteborg University,Clinical Neurochemistry Lab
[3] Sahlgrenska University Hospital,undefined
来源：
JNHA - The Journal of Nutrition, Health and Aging | 2009年 / 13卷
关键词：
Mild Cognitive Impairment; Lewy Body Dementia; BACE1 Inhibitor; Secretase Inhibitor; Mild Cognitive Impairment Case;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Use of biomarkers in Alzheimer's trials
    Vellas, B.
    JOURNAL OF NUTRITION HEALTH & AGING, 2009, 13 (04): : 331 - 331
  • [22] CSF and Blood Biomarkers for Alzheimer's Disease
    Herskovits, A. Zara
    Ivinson, Adrian J.
    Scherzer, Clemens R.
    Hyman, Bradley T.
    Lindeman, Neal
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 (03) : 469 - 469
  • [23] Novel CSF biomarkers for Alzheimer's disease
    Burchell, Jennifer T.
    Panegyres, Peter K.
    FUTURE NEUROLOGY, 2015, 10 (06) : 511 - 514
  • [24] Use of Biomarkers in Clinical Trials of Alzheimer Disease From Concept to Application
    Wu, Liyong
    Rosa-Neto, Pedro
    Gauthier, Serge
    MOLECULAR DIAGNOSIS & THERAPY, 2011, 15 (06) : 313 - 325
  • [25] The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trials
    Olsson, Bob
    Schott, Jonathan M.
    Blennow, Kaj
    Zetterberg, Henrik
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (08) : 767 - 775
  • [26] The role of biomarkers in clinical trials for Alzheimer disease
    Thal, LJ
    Kantarci, K
    Reiman, EM
    Klunk, WE
    Weiner, MW
    Zetterberg, H
    Galasko, D
    Praticò, D
    Griffin, S
    Schenk, D
    Siemers, E
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2006, 20 (01): : 6 - 15
  • [27] Alzheimer's disease and CSF biomarkers: key challenges for broad clinical applications
    Mattson, Niklas
    Zetterberg, Henrik
    BIOMARKERS IN MEDICINE, 2009, 3 (06) : 735 - 737
  • [28] Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios
    Bouwman, Femke H.
    Frisoni, Giovanni B.
    Johnson, Sterling C.
    Chen, Xiaochun
    Engelborghs, Sebastiaan
    Ikeuchi, Takeshi
    Paquet, Claire
    Ritchie, Craig
    Bozeat, Sasha
    Quevenco, Frances-Catherine
    Teunissen, Charlotte
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2022, 14 (01)
  • [29] Failure of Biomarkers in Clinical Trials of Alzheimer's Disease: Blaming the Messenger?
    Quinn, Joseph
    Clark, Christopher M.
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (01) : 103 - 104
  • [30] CSF biomarkers for Alzheimer's disease: current utility and potential future use
    Holtzman, David M.
    NEUROBIOLOGY OF AGING, 2011, 32 : S4 - S9
12345